Generation of four iPSC lines from Neurofibromatosis Type 1 patients by Kiymet Bozaoglu, Wei Shern Lee, Kristina M. Haebich, Kathryn N. North, Jonathan M. Payne, Paul J. Lockhart

Get full text

Sensory Processing in Children and Adolescents with Neurofibromatosis Type 1 by Natalie A. Pride, Kristina M. Haebich, Karin S. Walsh, Francesca Lami, Melissa Rouel, Alice Maier, Anita K. Chisholm, Jennifer Lorenzo, Stephen J. C. Hearps, Kathryn N. North, Jonathan M. Payne

Get full text

Delineating the autistic phenotype in children with neurofibromatosis type 1 by Anita K. Chisholm, Kristina M. Haebich, Natalie A. Pride, Karin S. Walsh, Francesca Lami, Alex Ure, Tiba Maloof, Amanda Brignell, Melissa Rouel, Yael Granader, Alice Maier, Belinda Barton, Hayley Darke, Gabriel Dabscheck, Vicki A. Anderson, Katrina Williams, Kathryn N. North, Jonathan M. Payne

Get full text

Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1 by Jonathan M. Payne, Stephen J. C. Hearps, Karin S. Walsh, Iris Paltin, Belinda Barton, Nicole J. Ullrich, Kristina M. Haebich, David Coghill, Gerard A. Gioia, Alan Cantor, Gary Cutter, James H. Tonsgard, David Viskochil, Celiane Rey‐Casserly, Elizabeth K. Schorry, Joseph D. Ackerson, Laura Klesse, Michael J. Fisher, David H. Gutmann, Tena Rosser, Roger J. Packer, Bruce Korf, Maria T. Acosta, Kathryn N. North, the NF Clinical Trials Consortium

Get full text